Your browser doesn't support javascript.
loading
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon, Yeongseon; Lee, Jeong-Won; Choi, Whan Soo; Won, Ji Eun; Kim, Ga Hee; Kim, Min Gi; Wi, Tae In; Lee, Jae Myeong; Kang, Tae Heung; Jung, In Duk; Cho, Young-Jae; Ahn, Hyung Jun; Shin, Byung Cheol; Lee, Young Joo; Sood, Anil K; Han, Hee Dong; Park, Yeong-Min.
Afiliação
  • Byeon Y; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Lee JW; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Choi WS; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Won JE; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Kim GH; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Kim MG; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Wi TI; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Lee JM; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Kang TH; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Jung ID; Department of Immunology, School of Medicine, Konkuk University, Chungju, South Korea.
  • Cho YJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Ahn HJ; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, South Korea.
  • Shin BC; Bio/Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
  • Lee YJ; Department of Bioscience and Biotechnology, Sejong University, Seoul, South Korea.
  • Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Han HD; Center for RNAi and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Park YM; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Res ; 78(21): 6247-6256, 2018 11 01.
Article em En | MEDLINE | ID: mdl-30115698
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Receptores de Hialuronatos / RNA Interferente Pequeno / Quinase 1 de Adesão Focal / Nanopartículas / Copolímero de Ácido Poliláctico e Ácido Poliglicólico / Carcinoma Epitelial do Ovário Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Receptores de Hialuronatos / RNA Interferente Pequeno / Quinase 1 de Adesão Focal / Nanopartículas / Copolímero de Ácido Poliláctico e Ácido Poliglicólico / Carcinoma Epitelial do Ovário Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Estados Unidos